Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Controlled Trial Examining the Use of The "Serious Illness Conversation Guide" (SICG) in Patients With Advanced Gastro-Intestinal Cancers

NCT04077372 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT04077372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04077372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Controlled Trial Examining the Use of The "Serious Illness Conversation Guide" (SICG) in Patients With Advanced Gastro-Intestinal Cancers
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Terminated
Start date
September 16, 2019
Completion date
October 11, 2020
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholangiocarcinoma, colorectal cancer, esophageal cancer, gastric cancer, gastrointestinal cancer, gist, malignant, hepatocellular carcinoma, neuroendocrine tumors, pancreatic adenocarcinoma